InvestSMART

Island Pharmaceuticals Limited (ASX: ILA) - Announcements

Current share price for ILA : $0.375 0.003 (0.66%)+

ASX company news and announcements for Island Pharmaceuticals Limited (ILA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Island Pharmaceuticals Limited (ILA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Island Pharmaceuticals Limited (ILA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Island Pharmaceuticals Limited (ILA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$111 Annual Report to Shareholders 17 Oct 2022 3:43PM $0.175 $0.375 risen by 114.29%
$111 Letter to Shareholders, Notice of AGM & Proxy Form 17 Oct 2022 3:42PM $0.175 $0.375 risen by 114.29%
$111 Date of AGM & Closing Date for Director Nominations 29 Sep 2022 9:04AM $0.175 $0.375 risen by 114.29%
$111 Appendix 4G 25 Aug 2022 4:29PM $0.170 $0.375 risen by 120.59%
$111 Corporate Governance Statement 25 Aug 2022 4:23PM $0.170 $0.375 risen by 120.59%
$111 Appendix 4E & Annual Report 25 Aug 2022 4:23PM $0.170 $0.375 risen by 120.59%
$111 Appendix 3Y - David Foster 4 Aug 2022 10:50AM $0.185 $0.375 risen by 102.70%
$111 Quarterly Activity Report & Appendix 4C 28 Jul 2022 9:45AM $0.150 $0.375 risen by 150%
$111 Notification regarding unquoted securities - ILA 21 Jul 2022 8:32AM $0.155 $0.375 risen by 141.94%
$111 Dr Amy Patick joins Island Scientific Advisory Board 19 Jul 2022 9:22AM $0.155 $0.375 risen by 141.94%
$111 Appendix 3Y - David Foster 22 Jun 2022 10:16AM $0.125 $0.375 risen by 200%
$111 Island to present at BIO International Convention 15 Jun 2022 12:29PM $0.130 $0.375 risen by 188.46%
$111 ISLA-101 manufacturing and timeline update 15 Jun 2022 10:06AM $0.160 $0.375 risen by 134.38%
$111 Change in substantial holding 28 Apr 2022 4:01PM $0.205 $0.375 risen by 82.93%
$111 Quarterly Activity Report & Appendix 4C 28 Apr 2022 1:22PM $0.190 $0.375 risen by 97.37%
$111 Updated Investor Presentation & Conference Participation 5 Apr 2022 8:24AM $0.215 $0.375 risen by 74.42%
$111 Change in substantial holding 31 Mar 2022 2:14PM $0.210 $0.375 risen by 78.57%
$111 Release of Securities from Escrow 25 Mar 2022 5:53PM $0.220 $0.375 risen by 70.45%
$111 Appendix 4D & Half-Year Financial Statements 24 Feb 2022 4:52PM $0.225 $0.375 risen by 66.67%
$111 Application for quotation of securities - ILA 17 Feb 2022 9:43AM $0.250 $0.375 risen by 50%
$111 Updated Investor Presentation & Webinar Invitation 10 Feb 2022 12:29PM $0.250 $0.375 risen by 50%
$111 Change in substantial holding 1 Feb 2022 5:02PM $0.250 $0.375 risen by 50%
$111 Release of Securities from Escrow 31 Jan 2022 4:12PM $0.240 $0.375 risen by 56.25%
$111 Quarterly Activity Report & Appendix 4C 27 Jan 2022 4:35PM $0.240 $0.375 risen by 56.25%
$111 Island executes PEACH clinical study CRO agreement 4 Jan 2022 9:05AM $0.255 $0.375 risen by 47.06%

351 - 375 of 455 results

Page 15 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.